Research map: Prevalence and determinants of dolutegravir resistance among people living with HIV with virologic failure in North-Eastern Uganda: a retrospective cross-sectional study (2022–2024)

Back to the article

Papers in this map

  1. The STROBE guidelines · Sarah Cuschieri · 2019 · 4292 citations · Cited by this paper
  2. Non-adherence and its predictors among pediatric household contacts on tuberculosis preventive therapy in the 3HP era: A multicenter observational study · 2026 · Related
  3. Substance Use: Impact on Adherence and HIV Medical Treatment · Adam Gonzalez · 2011 · 209 citations · Cited by this paper
  4. Successful use of isavuconazole as secondary prophylaxis of cryptococcal meningitis in a person living with HIV and AIDS: a case report · 2026 · Related
  5. Antiretroviral medication adherence and the development of class-specific antiretroviral resistance · Edward M. Gardner · 2009 · 162 citations · Cited by this paper
  6. Ensitrelvir in hospitalized patients with COVID-19 who were moderately to severely immunocompromised: a single-center cohort study · 2026 · Related
  7. Long-acting antiretrovirals and HIV treatment adherence · Jean Bisimwa Nachega · 2023 · 145 citations · Cited by this paper
  8. Entomo-virological surveillance of arboviruses in the Americas: prospects for the use of paper-based nucleic acid stabilization materials · 2025 · Related
  9. HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis · Tom Loosli · 2023 · 137 citations · Cited by this paper
  10. A new multiplex molecular assay based on padlock probes and rolling circle amplification for MDR-TB detection in clinical specimens: a prospective diagnostic accuracy study · 2026 · Related
  11. Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research · Jienchi Dorward · 2018 · 113 citations · Cited by this paper
  12. Micrococcus luteus -induced prosthetic valve infective endocarditis in an immunocompetent patient: a case report from India · 2025 · Related
  13. A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder · Alina Cernasev · 2021 · 98 citations · Cited by this paper
  14. Plazomicin in multidrug-resistant complicated urinary tract infections: a scoping review · 2025 · Related
  15. Substance Use Predictors of Poor Medication Adherence: The Role of Substance Use Coping Among HIV-Infected Patients in Opioid Dependence Treatment · Adam Gonzalez · 2012 · 96 citations · Cited by this paper
  16. Characterization of the clinical features, laboratory findings, and outcomes of human fascioliasis in a global network: a retrospective mutlicenter study · 2025 · Related
  17. Overestimation of Relative Risk and Prevalence Ratio: Misuse of Logistic Modeling · Charalambos Gnardellis · 2022 · 78 citations · Cited by this paper
  18. Enterovirus D68 and mycobacterial coinfection: case report · 2026 · Related
  19. The Relationship Between Resistance and Adherence in Drug-Naive Individuals Initiating HAART Is Specific to Individual Drug Classes · Lily Wai Yan Tam · 2008 · 57 citations · Cited by this paper
  20. European Society of Clinical Microbiology and Infectious Diseases Study Group for Artificial Intelligence and Digitalisation consensus statements on key aspects in the interaction of clinical microbiologists and infectious disease specialists with general-purpose large language model-based systems: project protocol · 2026 · Related
  21. Substance Use and Adherence to Antiretroviral Therapy: What Is Known and What Is Unknown · M. Eugenia Socías · 2018 · 57 citations · Cited by this paper
  22. Emergent Resistance to Dolutegravir Among INSTI-Naïve Patients on First-line or Second-line Antiretroviral Therapy: A Review of Published Cases · Müge Çevik · 2020 · 56 citations · Cited by this paper
  23. Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance survey · Doreen Kamori · 2023 · 43 citations · Cited by this paper
  24. Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil · Ricardo Sobhie Diaz · 2023 · 38 citations · Cited by this paper
  25. Emergence of Acquired Dolutegravir Resistance in Treatment-experienced People With HIV in Lesotho · Nadine Tschumi · 2024 · 35 citations · Cited by this paper
  26. The Phenomenon of Antiretroviral Drug Resistance in the Context of Human Immunodeficiency Virus Treatment: Dynamic and Ever Evolving Subject Matter · Miruna-Maria Apetroaei · 2024 · 33 citations · Cited by this paper
  27. Predicted dolutegravir resistance in people living with HIV in South Africa during 2020–35: a modelling study · Tom Loosli · 2025 · 27 citations · Cited by this paper
  28. Factors associated with HIV-1 resistance to integrase strand transfer inhibitors in Spain: Implications for dolutegravir-containing regimens · Horacio Gil · 2022 · 22 citations · Cited by this paper
  29. High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam · George Msema Bwire · 2023 · 22 citations · Cited by this paper
  30. HIV Medication Adherence and Substance Use: The Smartest Women’s Project · Eliot Jay Lopez · 2007 · 20 citations · Cited by this paper
  31. Pharmacokinetic Drug-Drug Interactions Involving Antiretroviral Agents: An Update · Xin Yu · 2023 · 14 citations · Cited by this paper
  32. The effect of substance uses on antiretroviral treatment adherence in primary health care · Ramprakash Kaswa · 2023 · 12 citations · Cited by this paper
  33. Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics · Elizabeth Zaniewski · 2024 · 11 citations · Cited by this paper
  34. Predictors of treatment-emergent resistance to dolutegravir · Suzanne M. McCluskey · 2025 · 9 citations · Cited by this paper
  35. HIV-1 drug resistance among people living with HIV receiving dolutegravir-based anti-retroviral regimens in Uganda: a national laboratory-based survey using remnant viral load samples, 2022 · Christine Watera · 2025 · 8 citations · Cited by this paper
  36. HIV drug resistance monitoring in the era of dolutegravir and injectable long-acting cabotegravir in resource-limited settings · Tendai Washaya · 2023 · 6 citations · Cited by this paper
  37. Prevalence and predictors of viral load non-suppression among adolescents on dolutegravir-based antiretroviral therapy: A cross-sectional study from three urban clinics, Soroti City · Connie Nait · 2025 · 6 citations · Cited by this paper
  38. HIV Dolutegravir resistance and multiclass failure in Mozambique: findings from a real-world cohort · Fausto Ciccacci · 2025 · 6 citations · Cited by this paper
  39. HIV-1 suppression and rare dolutegravir resistance in antiretroviral-experienced people with HIV in Liberia · James Soka Moses · 2025 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)